Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Beckman Coulter Diagnostics is committed to innovation and growth in Ireland
, /in Featured Articles /by panglobalIn July 2024, Beckman Coulter Diagnostics announced a €10 million investment and 80 jobs for its site in mid-west Ireland. CLI caught up with Kevin O’Reilly, President of Beckman Coulter Diagnostics, to find out more about the company’s aims, its commitment to the site in Ireland, and how a world-class diagnostics development facility can be […]
INTEGRA Your reliable partner for productive pipettes
, /in Featured Articles /by panglobalINTEGRA is a leading provider of high quality laboratory tools and consumables for liquid handling. We are committed to fulfilling the needs of laboratory professionals in research, diagnostics and quality control within the life sciences industry.
Biosynth’s custom peptide quotation tool now fully automatic
, /in Product News /by panglobalBiosynth, a supplier of critical raw materials and services for diagnostics, vaccines, and pharmaceuticals, has unveiled the next step in its custom peptide revolution.
Bio-Rad’s SpyLock technology accelerates bispecific antibody development
, /in Product News /by panglobalBio-Rad Laboratories has announced the publication of a study in Nature Communications demonstrating the utility of its SpyLock technology for rapid generation and screening of bispecific antibodies. The research, titled “Engineered Reversible Inhibition of SpyCatcher Reactivity Enables Rapid Generation of Bispecific Antibodies”, highlights a novel method to modify the functional activity of SpyCatcher protein, potentially […]
Indica Labs unveils AI-powered macrodissection tool for lung cancer
, /in Product News, Tumour Markers /by panglobalIn a significant advancement for molecular pathology, Indica Labs has launched Lung Macrodissect AI, a novel tool designed to streamline slide macrodissection workflows. The announcement marks a pivotal step in integrating artificial intelligence with digital pathology.
Medix Biochemica appoints IVD industry veteran to board
, /in E-News /by panglobalMedix Biochemica, a leading provider of in vitro diagnostics (IVD) raw materials, has announced the appointment of Lonnie Shoff to its Board of Directors. Shoff, formerly the President of the Clinical Diagnostics Division at Thermo Fisher Scientific, brings over 30 years of international healthcare experience to the role.
Synexa Life Sciences embraces sustainable laboratory practices
, /in E-News /by panglobalIn a notable move towards environmental responsibility within the life sciences sector, Synexa Life Sciences has announced its enrolment in the My Green Lab Certification Program. This strategic decision marks a significant step for the global biomarker and bioanalytical solutions provider in its quest to enhance the sustainability of its laboratory operations.
Touchlight and LenioBio collaborate to advance rapid vaccine development
, /in E-News /by panglobalIn a groundbreaking move towards accelerating pandemic response capabilities, Touchlight and LenioBio have announced a strategic partnership that could potentially transform the landscape of protein therapeutics development. This collaboration brings together two cutting-edge technologies in a bid to dramatically reduce the time required for vaccine production.
Annogen and Orchard Therapeutics join forces to develop CNS-specific promoters
, /in E-News, Molecular Diagnostics /by panglobalIn a significant move for gene therapy research, Annogen has announced a collaboration with Orchard Therapeutics to identify immune cell-specific human promoters for use in certain pre-clinical hematopoietic stem cell (HSC) gene therapy programmes. This partnership aims to advance the development of more targeted and potentially safer gene therapies for central nervous system (CNS) disorders.
Techbio startup Briefly Bio secures £1.2m to address reproducibility crisis in science
, /in E-News /by panglobalLondon-based startup Briefly Bio has launched with £1.2 million in pre-seed funding to tackle one of the most pressing issues in scientific research: reproducibility. With an estimated 50% of preclinical research experiments failing to be reproduced, costing the industry over £50 billion annually, Briefly Bio aims to revolutionise how scientists document and share their work.